Serum fetuin-A is correlated with metabolic syndrome in middle-aged and elderly Chinese

Pedersen, 1944, Fetuin, a new globulin isolated from serum, Nature, 154, 575, 10.1038/154575a0 Schafer, 2003, The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification, J Clin Invest, 112, 357, 10.1172/JCI17202 Price, 2003, The inhibition of calcium phosphate precipitation by fetuin is accompanied by the formation of a fetuin-mineral complex, J Biol Chem, 278, 22144, 10.1074/jbc.M300744200 Merx, 2005, Myocardial stiffness, cardiac remodeling, and diastolic dysfunction in calcification-prone fetuin-A-deficient mice, J Am Soc Nephrol, 16, 3357, 10.1681/ASN.2005040365 Ketteler, 2003, Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study, Lancet, 361, 827, 10.1016/S0140-6736(03)12710-9 Stenvinkel, 2005, Low fetuin-A levels are associated with cardiovascular death: impact of variations in the gene encoding fetuin, Kidney Int, 67, 2383, 10.1111/j.1523-1755.2005.00345.x Auberger, 1989, Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and anti-mitogenic activity, Cell, 58, 631, 10.1016/0092-8674(89)90098-6 Mathews, 2000, Alpha2-HSG, a specific inhibitor of insulin receptor autophosphorylation, interacts with the insulin receptor, Mol Cell Endocrinol, 164, 87, 10.1016/S0303-7207(00)00237-9 Mathews, 2002, Improved insulin sensitivity and resistance to weight gain in mice null for the Ahsg gene, Diabetes, 51, 2450, 10.2337/diabetes.51.8.2450 Ix, 2006, Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study, Circulation, 113, 1760, 10.1161/CIRCULATIONAHA.105.588723 Ix, 2008, Fetuin-A and incident diabetes mellitus in older persons, JAMA, 300, 182, 10.1001/jama.300.2.182 Stefan, 2008, Plasma fetuin-A levels and the risk of type 2 diabetes, Diabetes, 57, 2762, 10.2337/db08-0538 Reinehr, 2008, Fetuin-A and its relation to metabolic syndrome and fatty liver disease in obese children before and after weight loss, J Clin Endocrinol Metab, 93, 4479, 10.1210/jc.2008-1505 Gu, 2005, Prevalence of the metabolic syndrome and overweight among adults in China, Lancet, 365, 1398, 10.1016/S0140-6736(05)66375-1 Xiang, 2008, Zinc Transporter-8 gene (SLC30A8) is associated with type 2 diabetes in Chinese, J Clin Endocrinol Metab, 93, 4107, 10.1210/jc.2008-0161 Xu, 2009, Retinol-binding protein 4 is associated with impaired glucose regulation and microalbuminuria in a Chinese population, Diabetologia, 52, 1511, 10.1007/s00125-009-1386-8 2010 Ma, 2006, Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease, J Am Soc Nephrol, 17, 2937, 10.1681/ASN.2006040368 Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, 2001, Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III), JAMA, 285, 2486, 10.1001/jama.285.19.2486 Alberti, 2005, The metabolic syndrome – a new worldwide definition, Lancet, 366, 1059, 10.1016/S0140-6736(05)67402-8 Mori, 2006, Association of serum fetuin-A with insulin resistance in type 2 diabetic and nondiabetic subjects, Diabetes Care, 29, 468, 10.2337/diacare.29.02.06.dc05-1484 Stefan, 2006, Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans, Diabetes Care, 29, 853, 10.2337/diacare.29.04.06.dc05-1938 Ishibashi, 2010, Serum fetuin-A is an independent marker of insulin resistance in Japanese men, J Atheroscler Thromb, 17, 925, 10.5551/jat.3830 Wallace, 2004, Use and abuse of HOMA modeling, Diabetes Care, 27, 1487, 10.2337/diacare.27.6.1487 Denecke, 2003, Tissue distribution and activity testing suggest a similar but not identical function of fetuin-B and fetuin-A, Biochem J, 376, 135, 10.1042/bj20030676 Lin, 1998, Differential expression of insulin receptor tyrosine kinase inhibitor (fetuin) gene in a model of diet-induced obesity, Life Sci, 63, 145, 10.1016/S0024-3205(98)00250-1 Marchesini, 2001, Nonalcoholic fatty liver disease: a feature of the metabolic syndrome, Diabetes, 50, 1844, 10.2337/diabetes.50.8.1844 Hennige, 2008, Fetuin-A induces cytokine expression and suppresses adiponectin production, PLoS One, 3, e1765, 10.1371/journal.pone.0001765 Alberti, 2006, Metabolic syndrome – a new world-wide definition. A consensus statement from the International Diabetes Federation, Diabet Med, 23, 469, 10.1111/j.1464-5491.2006.01858.x Roos, 2010, Associations of fetuin-A levels with vascular disease in type 2 diabetes patients with early diabetic nephropathy, Cardiovasc Diabetol, 9, 48, 10.1186/1475-2840-9-48 Eraso, 2010, Association of lower plasma fetuin-a levels with peripheral arterial disease in type 2 diabetes, Diabetes Care, 33, 408, 10.2337/dc09-1541 Weikert, 2008, Plasma fetuin-a levels and the risk of myocardial infarction and ischemic stroke, Circulation, 118, 2555, 10.1161/CIRCULATIONAHA.108.814418